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Purpose
In the present study patients with optic neuritis were
treated with high dose prednisolone. Little information is
available about the effects of this treatment on ocular
blood flow. We set out to investigate the effects of high
dose prednisolone on optic nerve head blood flow in
patients with acute optic neuritis.
Methods
Nine patients with acute optic neuritis were included in
the study. One gram of prednisolone was infused intrave-
nously over 30 minutes on three consecutive days. On
each study day optic nerve head blood flow was measured
using laser Doppler flowmetry. The ocular hemodynamic
measurements were performed on the contralateral eye of
the patients with optic neuritis before and immediately
after cessation of the infusion. Intraocular pressure and
systemic blood pressure was measured before and after
the infusion on each study day. Data was analyzed using
a 3-2 repeated measures ANOVA model.
Results
Prednisolone increased optic nerve head blood flow in
the patients under study (p < 0.05). No significant change
in mean arterial pressure (p = 0.14) or intraocular pressure
(p = 0.91) could be detected in the patients treated with
high dose prednisolone.
Conclusion
High dose prednisolone showed a small but significant
increase in optic nerve head blood flow. Further studies
are required to study whether this effect contributes to the
therapeutic efficacy of cortisone in patients with optic
neuritis.
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